.Just five months after getting a $100 thousand IPO, Vast Bio is actually currently giving up some w...
.The initial phases of oncology R&D aren't except fascinating brand-new methods, as well as Halda...
.Psychopharmacology has taken three articles regarding midstage clinical trial data determining Lyko...
.Avidity Biosciences satisfied financiers with phase 1/2 information in Duchenne muscle dystrophy (D...
.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a phase 2 research study...
.Antibody-drug conjugates (ADCs) have actually been at the facility of several a billion-dollar biob...
.Resource supervisor TPG, which has actually sustained biotechs including Sionna Rehabs and also San...
.Merck & Co.'s TIGIT program has actually endured an additional trouble. Months after shuttering ...
.After a year determined by pipe cuts, the variation of its own CEO and also layoffs, Exscientia wil...
.Cullinan Therapy was thrilled enough with Port BioMed's bispecific immune activator that it handed ...